Mitomycin for pseudomyxoma peritonei

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 3 Mar 2021: Trial registered, NCT04779554
  2. 4 Jun 2021: Trial started, NCT04779554

The trials

NCT04779554: Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC

State
Under way
Phase
Phase 2
People
100 planned
Started
4 Jun 2021
Primary completion
Feb 2028
Arms
Flat Dose Mitomycin C, Weight-Based Mitomycin C
Results
None posted
  1. 3 Mar 2021: Trial registered
  2. 4 Jun 2021: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Also known as Ametycine, Jelmyto, Mitocin-c, Mitosol, Muamycin, Mutamycin, Mytozytrex, Mitomycin C, Zusduri.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.